SEC Form 3 · accession 0001209191-17-036474

VICAL INC · VICL

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Sr VP, Clinical Development

Period of report

May 25, 2017

Accepted (ET)

May 31, 2017 · 4:48 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000819050

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock	holding	—	—		—	9,399	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Employee Stock Option (Right to Buy)^F1	$2.31	holding	—	—	—	Jan 12, 2018	Jan 11, 2027	Common Stock	25,000	—	D
Employee Stock Option (Right to Buy)^F2	$2.31	holding	—	—	—	—	Jan 11, 2027	Common Stock	20,000	—	D
Employee Stock Option (Right to Buy)^F3	$3.56	holding	—	—	—	Jan 15, 2017	Jan 14, 2026	Common Stock	25,000	—	D
Employee Stock Option (Right to Buy)^F3	$10.70	holding	—	—	—	Jan 19, 2016	Jan 18, 2025	Common Stock	12,000	—	D
Employee Stock Option (Right to Buy)^F4	$14.20	holding	—	—	—	Jan 10, 2017	Jan 9, 2024	Common Stock	12,001	—	D
Employee Stock Option (Right to Buy)^F5	$13.60	holding	—	—	—	Aug 26, 2014	Aug 25, 2023	Common Stock	15,000	—	D
Employee Stock Option (Right to Buy)^F6	$33.80	holding	—	—	—	Nov 1, 2016	Oct 31, 2022	Common Stock	2,000	—	D

F125% of the shares subject to the stock option vest and become exercisable on the date reported in column 2 above, the first anniversary of the grant date. The remaining shares vest in equal quarterly installments over the remaining three years.
F250% of the shares subject to the stock option vest and become exercisable on each of January 12, 2018 and January 12, 2019.
F325% of the shares subject to the stock option vested and became exercisable on the date reported in column 2 above, the first anniversary of the grant date. The remaining shares vest in equal quarterly installments over the remaining three years.
F4The option became fully vested and exercisable on the date reported in column 2 above. One-third of the shares subject to the stock option vested and became exercisable on January 10, 2015, the first anniversary of the grant date. The remaining shares vested in equal quarterly installments thereafter.
F5The option became fully vested and exercisable on the date reported in column 2 above.
F6The option became fully vested and exercisable on the date reported in column 2 above. 25% of the shares subject to the stock option vested and became exercisable on November 1, 2013, the first anniversary of the grant date. The remaining shares vested in equal quarterly installments thereafter.

Securities acquired by the Reporting Person prior to May 26, 2016 reflect the 1-for-10 reverse split of the Issuer's common stock on such date.